CARDLYTICS INC
CDLXNASDAQTrading Snapshot
- Day Range
- $432.04 β $441.93
- 52-Week Range
- $3.00 β $26.70
- Volume
- $3.66B
- Avg Volume
- $2.66B
- Shares Outstanding
- 5.8M
- Next Earnings
- Dec 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $233M
- Last Q Revenue
- $37M
- P/E Ratio
- -0.2
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-17.41
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +4.1%
Why Investors Own CDLX
- βHigh-growth profile β revenue up -4.1% YoY with expanding US Equity exposure.
- βHealthy economics β 30% gross margin and 27% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CARDLYTICS INC
CDLXAbout CARDLYTICS INC
Cardlytics, Inc. provides an advertising platform, operating in both the United States and the United Kingdom. Among its key offerings is the Cardlytics platform, a proprietary advertising channel integrated directly into banks' digital environments. This system allows marketers to engage customers through the vast networks of their financial institution partners, leveraging digital avenues such as online portals, mobile applications, email, and various real-time alerts. Furthermore, the company offers the Bridg platform, a comprehensive customer data solution that processes point-of-sale information. This enables marketers to conduct advanced analytics, implement highly targeted loyalty initiatives, and precisely evaluate the performance of their marketing efforts. Cardlytics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
CARDLYTICS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CDLX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CARDLYTICS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.